Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399490 · ClinicalTrials.gov registry record · Phase 2
Open-label Extension Study Of RN624
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 287
- Enrollment target
NCT00399490 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 287 participants.
The verdict
NCT00399490, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 287 participants
- Enrollment target
Study Summary
Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basis.
Interventions
- DRUG RN624 (PF-04383119)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2006-09-15 |
| Est. Completion | 2008-02-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399490
The ClinicalTrials.gov registry entry for NCT00399490 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RN624 (PF-04383119) is the first listed.
NCT00399490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399490 about?
NCT00399490 is a clinical study titled "Open-label Extension Study Of RN624". Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basis.
What is the current status of trial NCT00399490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 287 participants. The study started on 2006-09-15. Estimated completion is 2008-02-11.
What interventions are being tested in trial NCT00399490?
The interventions under investigation include: RN624 (PF-04383119) (DRUG).
Who is sponsoring clinical trial NCT00399490?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.